US Patent Issued to MEDINCELL on Feb. 24 for "Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue" (French, Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,309, issued on Feb. 24, was assigned to MEDINCELL S.A. (Jacou, France).

"Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue" was invented by Georges Gaudriault (Montpellier, France), Sylvestre Grizot (Le Cres, France), Mark Hurtig (Ontario, Canada) and Matthew Shive (Denver).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copoly...